About Index Trending news
Analyze
Top 50 Pricing
miRagen Therapeutics

miRagen Therapeutics

Work at miRagen Therapeutics? Add yourself to this profile

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.

Elsewhere

Alexa global traffic share

Twitter followers

01 Nov 2016
$40,000,000
Venture capital (Series D)
Atlas Venture, MP Healthcare Venture Management, Fidelity Management and Research Company, +4

Miragen racks up $40 mln, will merge with Signal Genetics

PE HUB
18 Feb 2015
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
03 Jun 2009
$4,000,000
Venture capital (Series B)
Boulder Ventures, Broadview Ventures, Amgen, +1
19 May 2008
$8,000,000
Venture capital (Series A)